Search the GHTC website

Global health R&D delivers for New Hampshire

US government investment in global health R&D has delivered

$19.6 million
to New Hampshire research institutions
200+ new jobs
for New Hampshire
Global health R&D at work in New Hampshire

Cholera is an acute diarrheal disease that can kill within hours. Highly contagious, the disease is spread mainly by contaminated food and water. The disease has been around since ancient times, yet it remains a threat in many parts of the world. There are vaccines to prevent it; Since 2013, more than 15 million doses have been used in mass vaccination campaigns. But there is no cure. There remains millions of cases each year and an estimated 21,000 to 143,000 deaths from the disease. Researchers at the Dartmouth Geisel School of Medicine are working to end that. Their unique approach is to look at ways to turn off the genes that make cholera dangerous to humans. The drug therapy under development at Dartmouth aims not to kill the bacteria, but to render them harmless, making them less likely to mutate and become resistant to the drug.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: PATH/David Jacobs